powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1174973416
Matthew Trese
DO
Ophthalmology
Royal Oak,
MI
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 230130
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,009
Unique beneficiaries
—
Total services
16,268
Distinct HCPCS
19
Medicare payment
$1.4M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 608 Ophthalmology providers in MI — top quintile (cohort median 1,582).
PRESCRIBING · PART D · 2024
Total Rx claims
259
Beneficiaries
—
Total drug cost
$10K
Distinct drugs
7
Brand share
8.1%
Top prescribed drugs
Prednisolone Acetate
103 claims
Ketorolac Tromethamine
66 claims
Brimonidine Tartrate
27 claims
Dorzolamide Hcl/Timolol Maleat
21 claims
Latanoprost
16 claims
QUALITY · MIPS · 2024
Final MIPS score
95.3
Quality
91.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.85%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
22
By payment type
Food and Beverage
$2K
Top paying entities
Food and Beverage
$2K
